![Peter B. Heifetz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter B. Heifetz
Vorstandsvorsitzender bei OrPro Therapeutics, Inc.
Aktive Positionen von Peter B. Heifetz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Rincon Pharmaceuticals, Inc.
![]() Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rincon Pharmaceuticals, Inc. develops human therapeutic proteins. It develops and manufactures both partnered and proprietary products. The company was founded by Bruce D. Steel in 2004 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
OrPro Therapeutics, Inc.
![]() OrPro Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrPro Therapeutics, Inc. develops therapeutic platform based on thioredoxin, a human protein disulfide-reducing enzyme with unique mucus-normalizing, anti-inflammatory and anti-infective properties. The company is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Präsident | - | - | |
Unternehmenssekretär | - | - | |
Treasurer | - | - |
Karriereverlauf von Peter B. Heifetz
Ausbildung von Peter B. Heifetz
Duke University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Rincon Pharmaceuticals, Inc.
![]() Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rincon Pharmaceuticals, Inc. develops human therapeutic proteins. It develops and manufactures both partnered and proprietary products. The company was founded by Bruce D. Steel in 2004 and is headquartered in San Diego, CA. | Health Technology |
OrPro Therapeutics, Inc.
![]() OrPro Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrPro Therapeutics, Inc. develops therapeutic platform based on thioredoxin, a human protein disulfide-reducing enzyme with unique mucus-normalizing, anti-inflammatory and anti-infective properties. The company is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Peter B. Heifetz
- Erfahrung